Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicines Must Be Designated As Priority Items, Says IGBA

Action Needed To Speed Up Logistics Elements Around The World

Executive Summary

Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.

You may also be interested in...



Australian Bodies Set Out Joint Position On Coronavirus

Australia’s off-patent industry association, the GBMA, and local brand organization Medicines Australia have set out their plans for collaborating on supplying essential medicines amid the coronavirus pandemic. The move follows a recent temporary authorization by local competition regulator the ACCC that will allow the bodies to work more closely together.

Customs And Trade Bodies Join Forces To Minimize Disruption

The World Customs Organization and World Trade Organization have pledged to work together to break down trade barriers for essential supplies in the fight against the coronavirus pandemic.

Reduction In Flights Hits Global Supply Chain

Urgent action is needed to reopen air freight routes so that the global off-patent industry can deliver critical medicines and supplies amid the coronavirus pandemic, international industry representatives have insisted.

Related Content

Topics

UsernamePublicRestriction

Register

LL065251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel